Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Riluzole
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Riluzole 50mg tablets
0409030R0AAAAAA
|
Riluzole | Riluzole | Central Nervous System | 5,789 |
|
Riluzole 25mg/5ml oral suspension sugar free
0409030R0AAADAD
|
Riluzole | Riluzole | Central Nervous System | 1,066 |
|
Riluzole 50mg orodispersible films
0409030R0AAAEAE
|
Riluzole | Riluzole | Central Nervous System | 122 |
|
Teglutik 5mg/1ml oral suspension
0409030R0BCAAAD
|
Teglutik | Riluzole | Central Nervous System | 96 |
|
Rilutek 50mg tablets
0409030R0BBAAAA
|
Rilutek | Riluzole | Central Nervous System | 44 |
|
Emylif 50mg orodispersible films
0409030R0BDAAAE
|
Emylif | Riluzole | Central Nervous System | 26 |
|
Riluzole 50mg oral powder sachets
0409030R0AAABAB
|
Riluzole | Riluzole | Central Nervous System | No data available |
|
Riluzole 50mg/5ml oral liquid
0409030R0AAACAC
|
Riluzole | Riluzole | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.